Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Performance of Low-Dose Immunotherapy and Standard-Dose Immunotherapy in Microsatellite Instability-High Metastatic Colorectal Cancer: Real-World Data (CLouD-High Study).
Trikha M, Sarkar L, Dhanawat A, Syed N, Gujarathi H, Vora M, Sivakumar Raja AS, Bhargava P, Ramaswamy A, Mandavkar S, Saklani A, Kaushal RK, Bal M, Shetty O, Yadav S, Ostwal V. Trikha M, et al. JCO Glob Oncol. 2024 Aug;10:e2400141. doi: 10.1200/GO.24.00141. JCO Glob Oncol. 2024. PMID: 39159410
Gemcitabine Cisplatin and Durvalumab Experience in Advanced Biliary Tract Cancers: A Real-World, Multicentric Data From India.
Muddu VK, Shah A, John A, Raj A, Bahl A, Rajappa SJ, Raja T, Ghosh J, Lavingia V, Vora A, Bhargava P, Ramaswamy A, Khan A, Sharma A, Trikha M, Dhanawat A, Bonda A, Siripurapu I, Mahajan M, Rohatgi N, Chandrakant MV, Gujarathi H, Vora M, Ankathi S, Ostwal VS. Muddu VK, et al. Among authors: trikha m. JCO Glob Oncol. 2024 Dec;10:e2400216. doi: 10.1200/GO.24.00216. Epub 2024 Dec 5. JCO Glob Oncol. 2024. PMID: 39637344
Olanzapine as Antiemetic Prophylaxis in Moderately Emetogenic Chemotherapy: A Phase 3 Randomized Clinical Trial.
Ostwal V, Ramaswamy A, Mandavkar S, Bhargava P, Naughane D, Sunn SF, Srinivas S, Kapoor A, Mishra BK, Gupta A, Sansar B, Pal V, Pandey A, Bonda A, Siripurapu I, Muddu VK, Kannan S, Chaugule D, Patil R, Parulekar M, Dhanawat A, Trikha M, Ghosh J, Noronha V, Menon N, Patil V, Prabhash K, Olver I. Ostwal V, et al. Among authors: trikha m. JAMA Netw Open. 2024 Aug 1;7(8):e2426076. doi: 10.1001/jamanetworkopen.2024.26076. JAMA Netw Open. 2024. PMID: 39106066 Free PMC article. Clinical Trial.
A phase 1 clinical trial evaluating marizomib, pomalidomide and low-dose dexamethasone in relapsed and refractory multiple myeloma (NPI-0052-107): final study results.
Spencer A, Harrison S, Zonder J, Badros A, Laubach J, Bergin K, Khot A, Zimmerman T, Chauhan D, Levin N, MacLaren A, Reich SD, Trikha M, Richardson P. Spencer A, et al. Among authors: trikha m. Br J Haematol. 2018 Jan;180(1):41-51. doi: 10.1111/bjh.14987. Epub 2017 Oct 26. Br J Haematol. 2018. PMID: 29076150 Free PMC article. Clinical Trial.
Marizomib for central nervous system-multiple myeloma.
Badros A, Singh Z, Dhakal B, Kwok Y, MacLaren A, Richardson P, Trikha M, Hari P. Badros A, et al. Among authors: trikha m. Br J Haematol. 2017 Apr;177(2):221-225. doi: 10.1111/bjh.14498. Br J Haematol. 2017. PMID: 28387460 Free article.
50 results